
Shorter US Residence Linked to Greater CRC Screening Nonadherence
Key Takeaways
- Among 12,016 respondents in the 2023 NHIS, 31.8% were nonadherent, corresponding to a weighted nonadherence prevalence of 34.5% (95% CI, 33.4%-35.6%).
- Non–US-born adults had higher adjusted nonadherence versus US-born adults, strongest for <15 years’ residence (ARR, 1.25) and persisting at ≥15 years (ARR, 1.14).
Non-US-born adults had higher CRC screening nonadherence than US-born adults, particularly those with less than 15 years of US residence.
After adjustment for measured demographic, socioeconomic, and health care access factors,
Nativity and US Residence Duration as Factors in CRC Screening Adherence
CRC is considered largely preventable through screening, with the US Preventive Services Task Force (USPSTF)
With this in mind, investigators noted that nativity and duration of US residence may reflect migration-related factors not fully captured by race, ethnicity, conventional socioeconomic variables, or measured indicators of health care access. They therefore evaluated the association of nativity and duration of US residence with nonadherence to CRC screening guidelines among adults after the 2021 update.
For the cross-sectional study, the researchers analyzed data from adults aged 45 to 75 years without a self-reported cancer history who participated in the 2023 National Health Interview Survey. Participants were categorized by nativity and duration of US residence as US-born, non-US-born residing in the US for less than 15 years, or non-US-born residing in the US for 15 years or longer.
The study’s primary end point was nonadherence to USPSTF-recommended CRC screening, defined as not being up-to-date with any recommended screening modality within guideline-concordant intervals. The researchers applied survey weights, strata, and primary sampling units, adjusting models for age, sex, region, educational attainment, income-to-poverty ratio, marital status, insurance status, usual source of care, delayed care due to cost, and race and ethnicity.
Immigrant Adults Face Greater CRC Screening Barriers
The study population consisted of 12,016 participants, representing 95,399,898 US adults, with a weighted mean (SD) age of 58.8 (8.5) years. Of these participants, 6376 (50.8%) were female, and 5640 (49.2%) were male. Regarding race and ethnicity, 8208 (64.8%) self-reported being non-Hispanic White, 1553 (15.6%) Hispanic, 1430 (11.5%) non-Hispanic Black, and 825 (8.1%) other races and ethnicities.
A total of 3826 participants (31.8%) were nonadherent to recommended CRC screening, corresponding to a weighted prevalence of 34.5% (95% CI, 33.4%-35.6%). Compared with US-born adults, screening nonadherence was higher among non–US-born adults residing in the US for less than 15 years (adjusted risk ratio [ARR], 1.25; 95% CI, 1.09-1.43; P = .001) and those in the country for 15 years or longer (ARR, 1.14; 95% CI, 1.04-1.24; P = .004). Other factors associated with nonadherence included lacking a usual source of care (ARR, 1.61; 95% CI, 1.50-1.72; P < .001) and being uninsured (ARR, 1.47; 95% CI, 1.35-1.60; P < .001).
Similarly, adjusted screening nonadherence was highest among uninsured adults, those without a usual source of care, and those aged 45 to 49 years. The researchers observed multiplicative interactions for insurance status, usual source of care, and age group. Specifically, the relative associations between nativity and screening nonadherence were attenuated among adults aged 45 to 49 years compared with those aged 50 to 75 years, whereas adjusted absolute differences were broadly similar between age groups.
Implications for Equitable CRC Screening
The authors acknowledged their study’s limitations, including its cross-sectional design and possible residual confounding or selection associated with excluding respondents with missing data. Other limitations include self-reported screening and limited precision in some estimates for adults residing in the US for less than 15 years.
At the same time, they emphasized that their findings extend prior work by evaluating US residence duration across the full age range eligible under the current guideline and by examining differences across age and health care access strata.
“These findings suggested that expanding screening eligibility alone may be insufficient to achieve equitable CRC prevention,” the authors wrote. “Strategies are also needed for addressing persistent barriers to screening uptake and completion among immigrant populations.”
References
- Ekenze SO, Mevawalla A, Kibria AE, Yuza K, Elemosho A, Pawlik TM. Nativity and US residence duration and colorectal cancer screening nonadherence. JAMA Netw Open. 2026;9(10):e2639442. doi:10.1001/jamanetworkopen.2026.39442
- Davidson KW, Barry MJ, Mangione CM, et al; US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977. doi:10.1001/jama.2021.6238
Related to this article








